Embedded Files
May 13 2025, 12:00
PEGS meeting 2025 in Boston
PEGS meeting 2025 in Boston
Apr 23 2025, 12:00
ACRR Annual Meeting 2025 in Chicago!
ACRR Annual Meeting 2025 in Chicago!
Sep 11 2024, 12:00
ESMO 2024 in Barcelona!
ESMO 2024 in Barcelona
Part of our team will be engaging in great scientific conversations at ESMO 2024 in Barcelona, from September 13-17. If you're attending, be sure to connect with @Matthias to learn about our latest advancements!
#ESMO24 #Science #Medicine #Oncology #Tacalyx
Aug 30 2024, 12:00
EORTC-NCI-AACR 2024 in Barcelona
Our scientific team will present two posters at ENA 2024 in Barcelona (October 23-25)! 🎉 Will you be attending? If so, don’t miss the chance to meet @Wiebke and @Gustavo as they showcase our latest advancements and technologies!
Jun 14 2024, 12:00
Oren Moscovitz Wins Prestigious Hermann Neuhaus Prize
Dr. Oren Moscovitz has been awarded €25,000 by the Max Planck Society for his promising research toward treatments and non-invasive diagnostics for cancer, which could potentially reduce overall cancer-related deaths. Moscovitz and his team exploit unique sugar patterns found on cancer cells and develop ultra-small antibodies from alpacas (known as nanobodies) that bind to these sugars.
Â
https://www.mpikg.mpg.de/6834320/hermannneuhaus-prize-for-moscovitz?c=132305
Apr 08 2024, 18:00
TCX-101
TCX-101 TCX-101, a novel antibody-drug conjugate targeting a tumor- associated carbohydrate antigen for the treatment of solid tumors
Mar 28 2024, 18:00
Tacalyx to present at AACR 2024
Tacalyx to present at AACR 2024 TCX-101, a novel antibody-drug conjugate targeting a tumor-associated carbohydrate antigen for the treatment of solid tumors
F. G. Gomes, F. Muraca, G. M. Schmidt Garcia Moreira, K. Rösch, M. Bräutigam, P. Sondermann, M. OckerÂ
Monday, 8th April, 1:30 - 5:00 PM (PST) Session PO.ET02.01 - Antibody Drug Conjugates (Section 21) Poster 3125/ 6
Mar 15 2024, 18:00
AACR Annual Meeting 2024 in San Dieg
"This event is a fantastic opportunity for us to showcase our latest advancements and explore partnerships to further elevate our cancer research." MATTHIAS OCKER Head of Experimental Medicine at Tacalyx
Jun 05 2023, 12:00
Tacalyx and Leiden University Medical Center join forces to target tumor specific glycans in colorectal cancer € 500 K Health~Holland grant for new initiative against colorectal cancer. Read the full press release here:
Nov 05 2020, 12:00
Tacalyx Appoints Dr. Klaus Schollmeier as Chairman of the Board Senior Pharma/Biotech and Life Science Expert joins Tacalyx´s Board of Directors as Chairman. Read the full press release here:
Sep 25 2019, 14:00
Tacalyx Raises €7 Million in Seed Funding to Generate First in Class Anti-TACA Antibodies for Cancer Treatment Read the full press release here:
Page updated
Google Sites
Report abuse